No photo of Pin-Nan Cheng

View Scopus Profile

Pin-Nan Cheng

Doctor

  • 631 Citations
  • 13 h-Index
19962019
If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 中山醫學院醫學系學士

Experience

  • 1992年08月 ~迄今 胃腸肝膽科醫師

Fingerprint Dive into the research topics where Pin-Nan Cheng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 26 Similar Profiles
Hepacivirus Medicine & Life Sciences
Chronic Hepatitis C Medicine & Life Sciences
Chronic Hepatitis B Medicine & Life Sciences
Virus Diseases Medicine & Life Sciences
Ribavirin Medicine & Life Sciences
Hepatitis B virus Medicine & Life Sciences
Hepatitis B e Antigens Medicine & Life Sciences
Liver Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 631 Citations
  • 13 h-Index
  • 61 Article
  • 1 Review article

Augmenting central arterial stiffness following eradication of HCV by direct acting antivirals in advanced fibrosis patients

Cheng, P-N., Chen, Z-Y., Chiu, Y-C., Chiu, H-C. & Tsai, L-M., 2019 Dec 1, In : Scientific reports. 9, 1, 1426.

Research output: Contribution to journal › Article

Vascular Stiffness
Antiviral Agents
Fibrosis
Chronic Hepatitis C
Blood Pressure

Combined transarterial embolization/ chemoembolization-based locoregional treatment with sorafenib prolongs the survival in patients with advanced hepatocellular carcinoma and preserved liver function: A propensity score matching study

Chien, S. C., Chen, C-Y., Cheng, P-N., Liu, Y. S., Cheng, H-C., Chuang, C-H., Chang, T-T., Chiu, H. C., Lin, Y-J. & Chiu, Y-C., 2019 Jan 1, In : Liver Cancer. 8, 3, p. 186-202 17 p.

Research output: Contribution to journal › Article

Propensity Score
Hepatocellular Carcinoma
Survival
Liver
Liver Neoplasms
1 Citation (Scopus)

Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions

Yu, M. L., Hung, C. H., Huang, Y. H., Peng, C. Y., Lin, C. Y., Cheng, P-N., Chien, R. N., Hsu, S. J., Liu, C. H., Huang, C. F., Su, C. W., Huang, J. F., Liu, C. J., Kao, J. H., Chuang, W. L., Chen, P. J. & Chen, D. S., 2019 Feb 1, In : Journal of the Formosan Medical Association. 118, 2, p. 556-564 9 p.

Research output: Contribution to journal › Article

Open Access
Ribavirin
Genotype
Safety
Infection
Galectin 3
2 Citations (Scopus)

Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia–Pacific region and Russia: Final results from the randomized C-CORAL study

on behalf of the C-CORAL Investigators, 2019 Jan 1, In : Journal of Gastroenterology and Hepatology (Australia). 34, 1, p. 12-21 10 p.

Research output: Contribution to journal › Article

Open Access
Russia
Hepacivirus
Genotype
Safety
Infection
5 Citations (Scopus)

Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals

Bazerbachi, F., Haffar, S., Wang, Z., Cabezas, J., Arias-Loste, M. T., Crespo, J., Darwish-Murad, S., Ikram, M. A., Olynyk, J. K., Gan, E., Petta, S., Berzuini, A., Prati, D., de Lédinghen, V., Wong, V. W., Del Poggio, P., Chávez-Tapia, N. C., Chen, Y. P., Cheng, P-N., Yuen, M. F. & 23 others, Das, K., Chowdhury, A., Caballeria, L., Fabrellas, N., Ginès, P., Kumar, M., Sarin, S. K., Conti, F., Andreone, P., Sirli, R., Cortez-Pinto, H., Carvalhana, S., Sugihara, T., Kim, S. U., Parikh, P., Chayama, K., Corpechot, C., Kim, K. M., Papatheodoridis, G., Alsebaey, A., Kamath, P. S., Murad, M. H. & Watt, K. D., 2019 Jan 1, In : Clinical Gastroenterology and Hepatology. 17, 1, p. 54-64.e1

Research output: Contribution to journal › Review article

Reference Values
Liver
Elasticity Imaging Techniques
Fibrosis
Dyslipidemias